|
⚲
|
| Keyboard |
| Pfizer Ventures US LLC
✚
|
|
|---|---|
| CIK # | 0001776087 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001776087] | |
| 4 | [0001776087] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Pyxis Oncology Inc PYXS
Common Stock, $0.001 par value per share
|
2023-03-17 | Buy | 1,811,594 | $2.76 | 4,999,999 |
|
BioAtla Inc BCAB
Series D Convertible Preferred Stock · derivative
|
2020-12-18 | Conversion | 2,238,090 | ||
|
BioAtla Inc BCAB
Common Stock
|
2020-12-18 | Conversion | 2,238,090 | ||
|
Quince Therapeutics Inc CRTX
Common Stock
|
2020-06-03 | Sell | 370,000 | $40.18 | 14,866,600 |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Conversion | 76,003 | ||
|
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
|
2020-03-16 | Conversion | 5,470,492 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Conversion | 300,752 | ||
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Conversion | 868,467 | ||
|
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
|
2020-03-16 | Conversion | 1,894,444 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
|
2020-03-16 | Conversion | 478,749 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Buy | 312,500 | $16.00 | 5,000,000 |
|
SpringWorks Therapeutics Inc SWTX
Series B Convertible Preferred Stock · derivative
|
2019-09-17 | Conversion | 3,465,571 | $0.00 | |
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2019-09-17 | Buy | 50,000 | $18.00 | 900,000 |
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2019-09-17 | Conversion | 526,602 | ||
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2019-09-17 | Conversion | 978,194 | ||
|
SpringWorks Therapeutics Inc SWTX
Common Stock
|
2019-09-17 | Conversion | 3,039,051 | ||
|
SpringWorks Therapeutics Inc SWTX
Series A Convertible Preferred Stock · derivative
|
2019-09-17 | Conversion | 20,000,000 | $0.00 | |
|
SpringWorks Therapeutics Inc SWTX
Junior Series A Convertible Preferred Stock · derivative
|
2019-09-17 | Conversion | 6,437,500 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Common Stock
|
2019-05-13 | Conversion | 215,697 | $0.00 | |
|
Quince Therapeutics Inc CRTX
Series B Redeemable Convertible Preferred Stock · derivative
|
2019-05-13 | Conversion | 624,205 | $0.00 | |
| showing 20 of 25 most recent transactions | |||||